163 related articles for article (PubMed ID: 24481838)
1. Hippo activation in arrhythmogenic cardiomyopathy.
Hu Y; Pu WT
Circ Res; 2014 Jan; 114(3):402-5. PubMed ID: 24481838
[No Abstract] [Full Text] [Related]
2. The hippo pathway is activated and is a causal mechanism for adipogenesis in arrhythmogenic cardiomyopathy.
Chen SN; Gurha P; Lombardi R; Ruggiero A; Willerson JT; Marian AJ
Circ Res; 2014 Jan; 114(3):454-68. PubMed ID: 24276085
[TBL] [Abstract][Full Text] [Related]
3. Genetic and epigenetic regulation of arrhythmogenic cardiomyopathy.
Mazurek S; Kim GH
Biochim Biophys Acta Mol Basis Dis; 2017 Aug; 1863(8):2064-2069. PubMed ID: 28454914
[TBL] [Abstract][Full Text] [Related]
4. Genetic fate mapping identifies second heart field progenitor cells as a source of adipocytes in arrhythmogenic right ventricular cardiomyopathy.
Lombardi R; Dong J; Rodriguez G; Bell A; Leung TK; Schwartz RJ; Willerson JT; Brugada R; Marian AJ
Circ Res; 2009 May; 104(9):1076-84. PubMed ID: 19359597
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms of arrhythmogenic cardiomyopathy.
Austin KM; Trembley MA; Chandler SF; Sanders SP; Saffitz JE; Abrams DJ; Pu WT
Nat Rev Cardiol; 2019 Sep; 16(9):519-537. PubMed ID: 31028357
[TBL] [Abstract][Full Text] [Related]
6. Profiling of differentially expressed microRNAs in arrhythmogenic right ventricular cardiomyopathy.
Zhang H; Liu S; Dong T; Yang J; Xie Y; Wu Y; Kang K; Hu S; Gou D; Wei Y
Sci Rep; 2016 Jun; 6():28101. PubMed ID: 27307080
[TBL] [Abstract][Full Text] [Related]
7. Arrhythmogenic Cardiomyopathy: the Guilty Party in Adipogenesis.
Stadiotti I; Catto V; Casella M; Tondo C; Pompilio G; Sommariva E
J Cardiovasc Transl Res; 2017 Dec; 10(5-6):446-454. PubMed ID: 28983804
[TBL] [Abstract][Full Text] [Related]
8. Arrhythmogenic right ventricular cardiomyopathy: new insights into mechanisms of disease.
Saffitz JE; Asimaki A; Huang H
Cardiovasc Pathol; 2010; 19(3):166-70. PubMed ID: 20051321
[TBL] [Abstract][Full Text] [Related]
9. Reconciling the protean manifestations of arrhythmogenic cardiomyopathy.
Sen-Chowdhry S; McKenna WJ
Circ Arrhythm Electrophysiol; 2010 Dec; 3(6):566-70. PubMed ID: 21156776
[No Abstract] [Full Text] [Related]
10. Distinct molecular signature of phospholamban p.Arg14del arrhythmogenic cardiomyopathy.
Te Rijdt WP; Asimaki A; Jongbloed JDH; Hoorntje ET; Lazzarini E; van der Zwaag PA; de Boer RA; van Tintelen JP; Saffitz JE; van den Berg MP; Suurmeijer AJH
Cardiovasc Pathol; 2019; 40():2-6. PubMed ID: 30763825
[TBL] [Abstract][Full Text] [Related]
11. Deciphering the Role of Wnt and Rho Signaling Pathway in iPSC-Derived ARVC Cardiomyocytes by In Silico Mathematical Modeling.
Parrotta EI; Procopio A; Scalise S; Esposito C; Nicoletta G; Santamaria G; De Angelis MT; Dorn T; Moretti A; Laugwitz KL; Montefusco F; Cosentino C; Cuda G
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670616
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanisms in the pathogenesis of arrhythmogenic cardiomyopathy.
Saffitz JE
Cardiovasc Pathol; 2017; 28():51-58. PubMed ID: 28319834
[TBL] [Abstract][Full Text] [Related]
13. When rare illuminates common: how cardiocutaneous syndromes transformed our perspective on arrhythmogenic cardiomyopathy.
Sen-Chowdhry S; McKenna WJ
Cell Commun Adhes; 2014 Feb; 21(1):3-11. PubMed ID: 24460197
[TBL] [Abstract][Full Text] [Related]
14. Clinical and genetic characterization of families with arrhythmogenic right ventricular dysplasia/cardiomyopathy provides novel insights into patterns of disease expression.
Sen-Chowdhry S; Syrris P; Ward D; Asimaki A; Sevdalis E; McKenna WJ
Circulation; 2007 Apr; 115(13):1710-20. PubMed ID: 17372169
[TBL] [Abstract][Full Text] [Related]
15. A case of arrhythmogenic right ventricular cardiomyopathy (ARVC/D) in which tenascin C immunostaining made the assessment of myocardial remodeling possible.
Kondo T
Soud Lek; 2014 Jul; 59(3):24-5. PubMed ID: 25186773
[TBL] [Abstract][Full Text] [Related]
16. Integrin β1D Deficiency-Mediated RyR2 Dysfunction Contributes to Catecholamine-Sensitive Ventricular Tachycardia in Arrhythmogenic Right Ventricular Cardiomyopathy.
Wang Y; Li C; Shi L; Chen X; Cui C; Huang J; Chen B; Hall DD; Pan Z; Lu M; Hong J; Song LS; Zhao S
Circulation; 2020 May; 141(18):1477-1493. PubMed ID: 32122157
[TBL] [Abstract][Full Text] [Related]
17. Is it time for plakoglobin immune-histochemical diagnostic test for arrhythmogenic cardiomyopathy in the routine pathology practice?
Basso C; Pilichou K; Thiene G
Cardiovasc Pathol; 2013; 22(5):312-3. PubMed ID: 23856337
[No Abstract] [Full Text] [Related]
18. [Cardiomyopathy: progress in diagnosis and treatments. Topics: II. Secondary cardiomyopathy; 4. Arrhythmogenic right ventricular cardiomyopathy].
Nogami A
Nihon Naika Gakkai Zasshi; 2014 Feb; 103(2):316-26. PubMed ID: 24724372
[No Abstract] [Full Text] [Related]
19. Desmosome-ion channel interactions and their possible role in arrhythmogenic cardiomyopathy.
Delmar M
Pediatr Cardiol; 2012 Aug; 33(6):975-9. PubMed ID: 22407454
[TBL] [Abstract][Full Text] [Related]
20. Pathogenesis of arrhythmogenic cardiomyopathy: role of inflammation.
Lin YN; Ibrahim A; Marbán E; Cingolani E
Basic Res Cardiol; 2021 Jun; 116(1):39. PubMed ID: 34089132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
